Opko Health sold the assets of its CareEvolve subsidiary to ELLKAY LLC.
The Miami-based pharmaceutical, biotech and diagnostics company (Nasdaq: OPKO) led by Chairman and CEO Phillip Frost did not disclose the terms of the deal. Founded in 1999, CareEvolve runs a portal that allow laboratories and hospitals to communicate sensitive medical information.
CareEvolve was originally part of BioReference Laboratories, which Opko acquired in 2015.
“ELLKAY is an exemplary company in the healthcare connectivity…